Catheter Precision (Catheter Precision) Interest Expense : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Catheter Precision Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Catheter Precision's interest expense for the three months ended in Dec. 2023 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Catheter Precision's Operating Income for the three months ended in Dec. 2023 was $ -2.60 Mil. Catheter Precision's Interest Expense for the three months ended in Dec. 2023 was $ 0.00 Mil. GuruFocus does not calculate Catheter Precision's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Catheter Precision Interest Expense Historical Data

The historical data trend for Catheter Precision's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catheter Precision Interest Expense Chart

Catheter Precision Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.25

-0.11

Catheter Precision Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Catheter Precision Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Catheter Precision (AMEX:VTAK) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Catheter Precision's Interest Expense for the three months ended in Dec. 2023 was $0.00 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-2.60 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $0.10 Mil.

Catheter Precision's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

GuruFocus does not calculate Catheter Precision's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Catheter Precision Inc has enough cash to cover all of its debt. Its financial situation is stable.

Catheter Precision (Catheter Precision) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Catheter Precision Inc (AMEX:VTAK) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

4RM:Germany

Address

1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708

Website

https://www.ramed.com

Catheter Precision Inc Formerly Ra Medical Systems Inc is a commercial-stage medical device company whose business comprises of the design, manufacture and sale of new medical technologies in the field of cardiac electrophysiology, or EP. Its product, View into Ventricular Onset System or VIVO System which is a non invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. . It operates business as one segment which includes all activities related to the marketing, sales and development of medical technologies in the field of cardiac EP.

Executives

David A Jenkins	director, officer: Executive Chairman of Board	P.O. BOX 682838, PARK CITY UT 84068
Steven K Passey	officer: Chief Financial Officer	3216 SOUTH HIGHLAND DRIVE, SUITE 200, SALT LAKE CITY UT 84117
James Joseph Caruso	director	28 FIRST AVE, SEASIDE PARK NJ 08752
Brian Conn	officer: Chief Financial Officer	MICROISLET, INC., 6370 NANCY RIDGE DRIVE, SUITE 112, SAN DIEGO CA 92121
Andrew C. Jackson	officer: CFO & Secretary	11988 EL CAMINO REAL STE. 650, SAN DIEGO CA 92130
Jonathan Will Mcguire	director, officer: Chief Executive Officer	96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Susanne Meline	director	P.O. BOX 515381, #86506, LOS ANGELES CA 90051
Martin J Colombatto	director
Richard Jr Mejia	director	2200 FARADAY AVENUE, SUITE 100, CARLSBAD CA 92008
William R Enquist	director	11810 WILLS ROAD, ALPHARETTA GA 30009
Joan Stafslien	director	CAREFUSION CORPORATION, 3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Daniel Horwood	officer: General Counsel	C/O RA MEDICAL SYTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011
Jeffrey J Kraws	officer: Co-President	3985 RESEARCH PARK DRIVE, ANN ARBOR MI 48108
Dean Irwin	director, 10 percent owner, officer: See Remarks	C/O RA MEDICAL SYSTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011
Martin Burstein	10 percent owner	C/O RA MEDICAL SYSTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011